Artemether/Lemefantrine

Edina Avdic, Pharm.D.
Artemether/Lemefantrine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients with ≥ 5 kg.
    • Manufacturer does not recommend use for the treatment of severe malaria or the prevention of P. falciparum malaria.
    • Most recent CDC guidelines recommend artemether/lumefantrine use for the treatment of severe malaria following administration of IV artesunate or while waiting for IV artesunate to arrive from CDC (see CDC website)

NON-FDA APPROVED USES

  • Treatment of severe malaria due to P. falciparum following administration of IV artesunate or while awaiting for IV artesunate to arrive from CDC.
  • Treatment of uncomplicated P. vivax malaria (2015 WHO recommendations)[2].

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 6, 2019